The transient ischemic attack disease market was valued at USD 983.16 Million in 2024, fueled by the increasing emphasis on individualized treatments and advanced diagnostics innovations across 8 major markets. The market is anticipated to grow at a CAGR of 9.24% during the forecast period of 2025-2034, with the values likely to reach USD 2379.26 Million by 2034.
Base Year
Historical Year
Forecast Year
The rising incidence of cardiovascular diseases and the need for improved diagnostic techniques are major factors propelling the market value.
Global healthcare systems are emphasizing early diagnostic methods for transient ischemic attacks to lower stroke risk. This is leading to innovations in diagnostics such as MRI and 3D imaging for improving early identification and prompt interventions, influencing market dynamics positively.
The United States is expected to dominate the market because of its strong healthcare infrastructure. Nations like India are experiencing rapid growth driven by increasing healthcare funding and a boost in medical tourism.
Value in USD Million
2025-2034
Transient Ischemic Attack Disease Market Outlook
*this image is indicative*
Transient ischemic attack (TIA), often termed a "mini-stroke" is the temporary reduction of blood supply to a specific section of the brain, causing stroke-like symptoms that do not manifest any lasting symptoms. Rising cardiovascular disease rates, especially in aging populations, are driving demand for treatments for transient ischemic attacks. Some of the key trends influencing the market are the formulation of advanced imaging technologies, as well as preference for minimally invasive procedures. Several developments are impacting the market growth, as healthcare providers are aiming for targeted and patient-centred solutions in the identification of transient ischemic attack risks and the improvement of outcomes.
Rising Prevalence of Transient Ischemic Attack Disease Drives Market Growth
At least 240,000 people suffer from transient ischemic attacks each year in the United States. The growing incidence of cardiovascular diseases across the world is spurring demand for the treatments of the condition. As healthcare practitioners seek advanced solutions in managing risks linked with cardiovascular conditions, innovative treatment alternatives are expected to boost market growth in the forecast period.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Treatment
Market Breakup by Route of Administration
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on End User Holds a Significant Market Share
Based on end users, the market is divided into hospitals and clinics, diagnostic centers, research and academic institutes, and others. Among these, hospitals and clinics are predicted to lead the market since they function as essential centers for healthcare, offering access to numerous specialists. With easy patient access and an increasing need for advanced diagnostic tools, this segment is expected to hold a significant market share in the forecast period.
Based on the region, the market report offers insights into the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. Out of these, the United States is anticipated to lead the market with a robust healthcare infrastructure, and prominent healthcare companies at home are estimated to hold a high market value in the coming years. Increasing collaborations between academic institutions and several organizations to boost research initiatives also fuel the region’s market share.
India is projected to witness substantial growth, which can be accredited to increased expenditure to improve the healthcare infrastructure and cater to diverse patient demands. Owing to the presence of skilled healthcare practitioners, affordable procedures, and personalized care, the country is experiencing a surge in medical tourism. Consequently, they are likely to emerge as one of the major treatment hubs in the region.
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Johnson & Johnson is a global pharmaceutical company located in New Jersey, founded in 1886. The company obtained FDA approval for Varipulse, a pulsed field ablation device intended for treating drug-refractory paroxysmal atrial fibrillation, a condition that may result in transient ischemic attacks.
Eli Lilly & Co. was founded in 1876 and is based in Indianapolis, Indiana. Their main portfolio features Milvexian, an oral factor XIa inhibitor, currently being studied for stroke prevention following an acute ischemic stroke or high-risk TIA.
Bayer AG is a prominent pharmaceutical firm, based in Germany, and was founded in 1863. It creates various types of medications, such as Xarelto (rivaroxaban), which is an anticoagulant utilized to avert and manage blood clots, thus lowering the chances of stroke and transient ischemic attacks (TIAs).
Sanofi is a well-known healthcare firm founded in 1973 and based in France. Their primary product is Plavix (clopidogrel), an antiplatelet drug utilized to avert blood clots in individuals with cardiovascular conditions, including those susceptible to TIAs. Plavix is frequently recommended to lower the risk of stroke and heart attack in at-risk individuals.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Boehringer Ingelheim GmbH, Daiichi Sankyo, Inc., and Cigna Health Management Inc., among others.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment |
|
| Breakup by Route of Administration |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share